Xlife Sciences AG Key word Annual Results Xlife Sciences AG Publishes 2023 Annual Report 23Apr2024 0700 CETCEST Release of an ad hoc announcement pursuant to Art 53 LR The issuer is solely responsibl
Xlife Sciences AG Key word Mergers & AcquisitionsTakeover VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline 29Dec2023 1745 CETCEST Release of an ad hoc announcement pursuant to
Xlife Sciences AG Key word DisposalInvestment Successful exit of portfolio company and major invest in AI and digital health in early cancer detection valued at CHF 233 million 18Oct2023 0700 CETCEST
Xlife Sciences AG Key word Half Year Results Xlife Sciences with significant progress in H1 2023 21Sep2023 0700 CETCEST Release of an ad hoc announcement pursuant to Art 53 LR The issuer is solely re